Literature DB >> 673021

Inhibitory effect of tyramine-induced release of catecholamines on renin secretion.

D K Meyer, M Herrmann.   

Abstract

The effect of the indirect sympathomimetic agent tyramine on the isoprenaline-induced increase in plasma renin concentration was investigated in conscious rats. Tyramine caused a dose-dependent decrease in the isoprenaline-induced elevation of plasma renin concentration. Pretreatment of the rats with reserpine abolished this effect of tyramine, indicating that tyramine released catecholamines which acted on the inhibitory adrenoceptors. Pretreatment with phenoxybenzamine, an alpha-adrenoceptor antagonist, also abolished the inhibitory effect of tyramine on renin release, indicating that alpha-adrenoceptors mediated the observed inhibition of renin release. In rats with chronically denervated kidneys tyramine did not inhibit renin release. It is concluded that catecholamines which are released from renal sympathetic nerve endings can suppress renin release by activating alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673021     DOI: 10.1007/BF00508059

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  The effect of lanthanum on renin secretion and renal vasoconstriction.

Authors:  A G Logan; I Tenyi; W S Peart; A S Breathnach; B G Martin
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-01-14

2.  Studies concerning the mechanism of suppression of renin secretion by clonidine.

Authors:  I A Reid; D M MacDonald; B Pachnis; W F Ganong
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

3.  ON THE PRODUCTION AND ROLE OF RENIN.

Authors:  A C TAQUINI; P BLAQUIER; A C TAQUINI
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

4.  alpha-Adrenoceptor-mediated inhibitory effect of the sympathetic nervous system on the isoprenaline-induced increase in plasma renin concentration.

Authors:  D K Meyer; A Kempter; H Boll; M Eisenreich; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

5.  The inhibition of renin secretion by alpha-adrenergic stimulation in the isolated rat kidney.

Authors:  R Vandongen; W S Peart
Journal:  Clin Sci Mol Med       Date:  1974-11

6.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

7.  Andrenergic stimulation of renin secretion in the isolated perfused rat kidney.

Authors:  R Vandongen; W S Peart; G W Boyd
Journal:  Circ Res       Date:  1973-02       Impact factor: 17.367

8.  Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats.

Authors:  B Peskar; D K Meyer; U Tauchmann; G Hertting
Journal:  Eur J Pharmacol       Date:  1970-03       Impact factor: 4.432

9.  Regulation of renin release and intrarenal formation of angiotensin. Studies in the isolated perfused rat kidney.

Authors:  K G Hofbauer; H Zschiedrich; F Gross
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Jan-Feb       Impact factor: 2.557

10.  Suppression of isoprenaline-induced increase in plasma renin concentration by vasoconstrictors in rats with nonfunctioning Macula densa.

Authors:  D K Meyer; G Hertting; C Mittermayer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

View more
  2 in total

1.  Inhibitory effect of atropine on the isoprenaline-induced increase in vasopressin plasma concentration in rats.

Authors:  D K Meyer; K Wessel; W Knepel
Journal:  Experientia       Date:  1979-11-15

2.  The mechanism of yohimbine-induced renin release in the conscious rat.

Authors:  S L Pfister; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.